Track Drugs Made In America Acquisition II Unit's current assets ($140K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), DMIIU shows a current assets of $140K. That compares with $900K in the prior-year period — down 84.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DMIIU's current assets is now $140K (was $900K) — a 84.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Drugs Made In America Acquisition II Unit is outperforming or lagging.
Tracking DMIIU's current assets over time shows whether Drugs Made In America Acquisition II Unit is scaling, shrinking, or reshaping that part of the business. The current reading is $140K That compares with $900K in the prior-year period — down 84.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Drugs Made In America Acquisition II Unit's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $140K) with ownership activity and broader fundamentals.